TC
Tekla Capital Management
Venture CapitalActiveTekla Capital Management is an investment adviser.
29
Investments
4
Exits
$2.5B
AUM
13.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Tekla Capital Management.
Investment Thesis & Strategy
Tekla Capital Management invests in various stages across fintech, healthcare, and venture capital, seeking to advise and grow companies in these sectors.
Investment Activity
Deals per year over the last 16 years
3
20000
20012
20020
20031
20040
20050
20060
20070
20080
20090
20100
20111
20122
20132
20141
2015Portfolio Companies
Selected investments from their portfolio of 29 companies
V
Voyager Therapeutics
Biotech · Series A, 2015
I
Intellia Therapeutics
Biotech · Series A, 2014
C
CRISPR Therapeutics
Biotech · Series A, 2014
P
Portola Pharmaceuticals
Biotech · Growth, 2013
F
Fate Therapeutics
Biotech · Growth, 2013
b
bluebird bio
Biotech · Growth, 2012
A
Acadia Pharmaceuticals
Biotech · Growth, 2004
A
Alnylam Pharmaceuticals
Biotech · Growth, 2002
I
Incyte
Biotech · Growth, 2002
V
Vertex Pharmaceuticals
Biotech · Growth, 2000
R
Regeneron Pharmaceuticals
Biotech · Growth, 2000
B
BioMarin Pharmaceutical
Biotech · Growth, 2000
Notable Exits
CompanyTypeYearValue / Acquirer
Portola PharmaceuticalsAcquisition2020$1.4B
Esperion TherapeuticsIPO2013—
Acadia PharmaceuticalsIPO2004—
Seattle GeneticsIPO2001—
Frequently Asked Questions
Tekla Capital Management focuses on Series A, Series B, Series C+ stage investments.